We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Fujifilm to Develop AI-Based Technology for Analysis of Coronavirus-Induced Pneumonia

By HospiMedica International staff writers
Posted on 23 May 2020
Fujifilm Corporation (Tokyo, Japan) will begin a research study to develop Artificial Intelligence (AI)-based technology to aid in the diagnosis and treatment assessment of patients with COVID-19-induced pneumonia.

Fujifilm has been working on developing AI technology that can be used for assisting medical diagnostic imaging, facilitating workflow at the medical frontline and delivering maintenance services for medical equipment. More...
Fujifilm will apply the CT quantification technology for interstitial pneumonia to develop the technology that helps evaluate the progress of patients with COVID-19-induced pneumonia and determine the effectiveness of treatments.

Fujifilm's CT quantification technology for interstitial pneumonia is powered by an AI-based software that examines CT images to identify bronchi, blood vessels and normal lungs in lung field as well as seven types of lesions such as reticular opacities, ground-glass opacities and honeycomb lungs, and automatically carries out categorization and measurement to quantify lesions of interstitial pneumonia. It also divides the lung field into 12 zones and shows the volume and ratio of lesions for each of the zones so that clinicians can examine the distribution and progression of lesions within the lung field in details. In addition, the technology is expected to contribute to accelerating the development and evaluation of drug candidates for treating pneumonia induced by COVID-19.



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Resorbable Bovine Collagen Membrane
GenDerm
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Reusable catheter patients used 35 percent fewer antibiotics compared to their single-use only counterparts. (Photo courtesy of the University of Southampton)

Reusable Intermittent Catheters Reduce Antibiotic Use Without Increasing Urinary Tract Infections

Intermittent self-catheterization, used to empty the bladder several times a day, can leave patients vulnerable to recurrent urinary tract infections and repeated antibiotic use. Reliance on single-use... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.